08-Jan-2007 - US researchers have been awarded a patent for their new manufacturing technology which enables the quick and cheap production of nanoparticles used to formulate and deliver drugs - good news for NanoMed who has an exclusive licence for the technology.
08-Jan-2007 - The US Food and Drug Administration (FDA) has approved Janssen's new drug Invega (paliperidone); the first new prescription drug for the treatment of schizophrenia since 2003.
04-Jan-2007 - US researchers have combined cancer drug-carrying liposomes and heat, which accelerates drug release and delivers 30 times more drug to tumours, as visualised in vivo using magnetic resonance imaging (MRI)
03-Jan-2007 - A US pharmaceutical last month introduced a spearmint-flavoured chewable contraceptive pill as a 'more convenient' option for women 'on-the-go'.
20-Dec-2006 - Specialty pharmaceutical company CyDex has been boosted by the news that an intramuscular injection formulation of schizophrenia drug Abilify, which makes use of its Captisol solubility technology has been launched in the USA.
19-Dec-2006 - Researchers have discovered that using nanotechnology could help reduce fatalities from drug overdoses, as nanoparticles can act as potential antidotes.
19-Dec-2006 - Medicated chewing gum company Fertin Pharma has announced a collaboration with the US Army Dental Research and Trauma Detachment (USADRT) on the first antimicrobial chewing gum to lower incidences of disease and non-battle related injuries among soldiers.
18-Dec-2006 - Pharma company Shire has agreed with European regulators on labelling information for its ulcerative colitis drug Mezavant, a further step in the firm's ambition to capture more of the $1.6bn (€1.2bn) mesalazine market through its easy and effective delivery system.
18-Dec-2006 - Drug delivery company MonoSolRx has announced it has received a $38m (€29m) funding from an investment group, illustrating the appeal of the company's dissolving film technology.
14-Dec-2006 - The US Food and Drug Administration (FDA) has decided against restricting the use of drug-eluting cardiac stents after a two-day investigation into their potential to increase blood clots.
14-Dec-2006 - Dr Reddy's Laboratories has started first clinical trials of a "four-in-one" polypill clinical trial, which could revolutionise the cardiovascular drugs market.
13-Dec-2006 - Roche has invested $20m in a new technology that has the potential to dramatically enhance the delivery of subcutaneous drugs by acting like a 'molecular machete'.
12-Dec-2006 - US researchers have developed a novel delivery vehicle for siRNA, an up-and-coming technology for switching off genes in the body that could accelerate its use in drug development.
12-Dec-2006 - A new 'glass' making technique that improves stability and durability could lead to novel coatings and improvements in drug delivery, according to researchers at the University of Wisconsin-Madison and the National Institute of Standards and Technology (NIST) Centre for Neutron Research.
06-Dec-2006 - Nastech missed out on a $15m (€11m) milestone payment after having to delay the development of its new nasal spray for the treatment of osteoporosis because of the need of an additional clinical trial.
30-Nov-2006 - BioProgress last week announced an update to their agreement with licensing partner FMC Corporation for its oral drug delivery technology, NRobe.
30-Nov-2006 - Drug delivery specialist Iomai is testing a new flu vaccine which could make the use of needles unnecessary.
23-Nov-2006 - Scientists have discovered a new nanoparticule-based drug delivery system to treat brain cancer that it claims could revolutionise currently used chemotherapeutic treatments for this devastating type of cancer.
22-Nov-2006 - DSM Venturing, the investment arm of the Dutch chemical giant, has announced it has snapped a 10 per cent share in pharma materials provider Micromuscle.
22-Nov-2006 - Actelion has announced it is acquiring biopharmaceutical company CoTherix for $420m (€328m) with the objective of taking over and increasing the distribution of Ventavis, the only approved inhaled therapy for the treatment of Pulmonary Arterial Hypertension (PAH) in the US.
20-Nov-2006 - Vectura and Innovata have announced they are merging in a deal worth £128.8m with the objective of becoming UK's number one in the pulmonary drug development sector.
20-Nov-2006 - Australia's pSivida said that an undisclosed US firm is now evaluating its novel BioSilicon technology with the aim of developing new transdermal drug delivery systems.
08-Nov-2006 - Pharma company NovaDel has announced that the US regulators have given the thumbs up to its oral spray for relieving and preventing angina due to coronary artery disease.
31-Oct-2006 - A start-up company has given new hope for patients with brain tumour by developing a new medical device that it claims is the first ultrasound-based system to allow drug delivery to the brain.
27-Oct-2006 - A year after it published its five-year strategy: Vision 2010 - Building on Strengths - DSM's commitment is showing no sign of slowing as is continues to invest in the expansion of its pharmaceutical production capabilities around the globe.